Le Lézard
Classified in: Health
Subjects: SVY, WOM, MAT, DEI

ADAMEVE.COM ASKS "SHOULD ABORTION BE LEGALLY AVAILABLE TO WOMEN IN THE UNITED STATES?"


HILLSBOROUGH, N.C., Jan. 9, 2024 /PRNewswire/ -- Adam & Eve and adameve.com, America's most trusted source for adult products, aren't afraid to ask the hard questions when it comes to the current sexual culture in our country. This month, the company surveyed over 1000 people, asking if abortion should be legally available to women in the U.S. And the responses may surprise you.

While 47% of those surveyed felt that abortion should be legally available to women under any circumstance, 33% agreed that it should be legally available under certain circumstance. Nearly 15% of respondents said abortion should not be legally available, and an additional 5% said they weren't sure.

"The abortion debate will always be divisive," says Dr. Jenni Skyler, PhD, LMFT, CST, and resident sexologist at Adam & Eve. "Whether it's from a political, religious or cultural standpoint, everyone has a strong feeling about it. But at its core, abortion is a healthcare issue and a personal issue between a woman and her partner, and a woman and her doctor."

"Adam & Eve got its start providing condoms by mail, and we still offer a wide variety of condoms to support easy access to affordable birth control," says Chad Davis, Director of Marketing for Adam & Eve. "We encourage adults to explore their sexuality within their own comfort levels and boundaries."

The web-based survey, conducted by an independent third party survey company, of over 1,000 American adults age 18 and up, was sponsored by Adam & Eve to study sexual preferences and practices.

For more information about Adam & Eve, visit their website, https://www.adameve.com. For additional information on Adam & Eve, please contact Adam & Eve Director of Public Relations Katy Zvolerin at 919.644.8100 x 3121 or [email protected].

SOURCE adameve.com


These press releases may also interest you

at 06:50
Pfizer Inc. today announced that Andrew Baum, M.D., will join the company as Chief Strategy and Innovation Officer, Executive Vice President. Dr. Baum will be a member of Pfizer's Executive Leadership Team reporting to Chairman and Chief Executive...

at 06:30
Immunic, Inc. , a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases, today announced participation in the following investor and scientific...

at 06:25
Genenta Science , a clinical-stage immuno-oncology company developing a cell-based platform harnessing the power of hematopoietic stem cells to provide durable and safe treatments for solid tumors, announces that it held its Ordinary and...

at 06:19
Navamedic ASA (OSE: NAVA), a Nordic pharma company and reliable provider of high-quality products to hospitals and pharmacies has launched Eroxon® in Sweden. Eroxon® is clinically proven and considered a breakthrough in treatment of erectile...

at 06:05
Soleo Health, an innovative leader and national provider of complex specialty pharmacy services for treating rare- and ultra-rare diseases, announced today it has been named a limited distribution specialty pharmacy partner to dispense RYPLAZIM®...

at 06:05
GlycoMimetics, Inc. , a late clinical-stage biotechnology company discovering and developing glycobiology-based therapies for cancers and inflammatory diseases, today announced topline results from its Phase 3 global pivotal study of uproleselan in...



News published on and distributed by: